Zoetis maintains prevalent Real Value of $123.67 per share. The last-minute price of the organization is $124.27. At this time the organization appears to be fairly valued. This module calculates value of Zoetis from examining the organization fundamentals such as Current Valuation of 62.7B, Profit Margin of
22.74% and Return On Asset of 12.56% as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we encourage to purchase undervalued securities and to sell overvalued securities since at some point equities prices and their ongoing real values will grow together.
September 22, 2019
Zoetis is very steady asset. Calculation of real value of Zoetis is based on 3 months time horizon. Increasing Zoetis time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
Zoetis Market CapZoetis is rated fifth in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Specialty & Generic industry is at this time estimated at about 205.12 Billion. Zoetis totals roughly 57.14 Billion in market capitalization claiming about 28% of equities under Drug Manufacturers - Specialty & Generic industry.
|Horizon||30 Days Login to change|
Zoetis is rated below average in last dividend paid category among related companies. It is rated fifth in price to sales category among related companies fabricating about 14.32 of Price to Sales per Last Dividend Paid.
|Last Dividend Paid|
|Price to Sales ( times )|